Clinical Pharmacology of Drugs for HIV Prevention and Treatment (AME)

Watching this, you will understand the pharmacological properties and potential drug-drug interactions of oral integrase inhibitors, list the primary reasons for new child infections and outline the approaches to prevent mother-to-child HIV transmission, and map the available strategies and the existing barriers to effective prevention of new HIV infections in women and adolescents. 


​All modules can be followed independently and at your own pace. Complete the entire course to equip yourself with the knowledge to work towards making a significant impact on the survival and quality of life of your patients faced with these specific circumstances.

After following this eLearning activity, you will be able to:

- Understand pharmacological properties and potential drug-drug interactions of oral integrase inhibitors;

- List primary reasons for new child infections and outline approaches to prevent mother-to-child HIV transmission; and

- Map available strategies and existing barriers to effective prevention of new HIV infections in women and adolescents​.

To obtain your certificate, you have complete all three modules, passed the relevant assessments and answered the evaluation survey.


Module 1 | Drug-Drug Interactions With Oral INSTI


Module 2 | Updates on Preventing Mother-to-Child HIV Transmission


Module 3 | Preventing HIV Infection in Women and Adolescents


Duration: approximately 20 minutes per module

You can enhance your learning experience by:

- adding notes to the video modules;

- consulting the accompanying presentation slides;

- sharing your questions and observations with other learners in the discussion board; and

- referring to further literature and other materials provided to you by our experts.

The program is aimed at clinicians from various specialties who occasionally treat HIV patients, such as primary care physicians, family doctors, OBGYN, transgender healthcare clinicians, adolescent medicine professionals, and preventive medicine professionals, as well as public health workers and researchers engaged in HIV related disciplines at varying degrees.